Found: 28
Select item for more details and to access through your institution.
The Frequency of Differentiated Thyroid Cancer Recurrence in 2302 Patients With Excellent Response to Primary Therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 2, p. e569, doi. 10.1210/clinem/dgad571
- By:
- Publication type:
- Article
Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2438, doi. 10.3390/jcm10112438
- By:
- Publication type:
- Article
The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0133852
- By:
- Publication type:
- Article
A Significance of Concomitant BRAF<sup>V600E</sup> and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.
- Published in:
- Thyroid, 2022, v. 32, n. 11, p. 1372, doi. 10.1089/thy.2022.0155
- By:
- Publication type:
- Article
Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF<sup>V600E</sup> Mutation: A Single-Institution Study.
- Published in:
- Thyroid, 2016, v. 26, n. 4, p. 543, doi. 10.1089/thy.2015.0352
- By:
- Publication type:
- Article
Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 815, doi. 10.3390/cancers16040815
- By:
- Publication type:
- Article
Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 470, doi. 10.3390/cancers13030470
- By:
- Publication type:
- Article
Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 423, doi. 10.3390/cancers12020423
- By:
- Publication type:
- Article
Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1744, doi. 10.3390/cancers11111744
- By:
- Publication type:
- Article
Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
- Published in:
- Endocrinology, 2019, v. 160, n. 10, p. 2328, doi. 10.1210/en.2019-00315
- By:
- Publication type:
- Article
Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229264
- By:
- Publication type:
- Article
CHEK 2 mutations and the risk of papillary thyroid cancer.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 3, p. 548, doi. 10.1002/ijc.29426
- By:
- Publication type:
- Article
The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153242
- By:
- Publication type:
- Article
Unusual case of radioactive iodine-induced Graves' disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2020, v. 71, n. 3, p. 277, doi. 10.5603/EP.a2020.0019
- By:
- Publication type:
- Article
Two cases of pheochromocytoma in pregnancy: a multidisciplinary challenge.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2020, v. 71, n. 1, p. 98, doi. 10.5603/EP.a2019.0039
- By:
- Publication type:
- Article
The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2019, v. 70, n. 3, p. 232, doi. 10.5603/EP.a2019.0008
- By:
- Publication type:
- Article
The usefulness of determining the presence of BRAF V600E mutation in fine-needle aspiration cytology in indeterminate cytological results.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2016, v. 67, n. 1, p. 41, doi. 10.5603/EP.2016.0006
- By:
- Publication type:
- Article
Primary hyperparathyroidism: a rare endocrinopathy in children. Two case reports.
- Published in:
- Polish Journal of Endocrinology / Endokrynologia Polska, 2011, v. 62, n. 4, p. 346
- By:
- Publication type:
- Article
Late-Onset Medullary Thyroid Cancer in a Patient with a Germline RET Codon C634R Mutation.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 8, p. 1448, doi. 10.3390/diagnostics11081448
- By:
- Publication type:
- Article
Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
- Published in:
- Endocrine Pathology, 2020, v. 31, n. 2, p. 143, doi. 10.1007/s12022-020-09619-0
- By:
- Publication type:
- Article
Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy.
- Published in:
- Genes, 2021, v. 12, n. 10, p. 1534, doi. 10.3390/genes12101534
- By:
- Publication type:
- Article
The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204668
- By:
- Publication type:
- Article
Pseudohypoparathyroidism type 1a caused by a GNAS gene mutation: over 40 years without a proper diagnosis.
- Published in:
- Polish Archives of Internal Medicine, 2022, v. 132, n. 2, p. 1, doi. 10.20452/pamw.16153
- By:
- Publication type:
- Article
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 12, p. 10019, doi. 10.3390/ijms241210019
- By:
- Publication type:
- Article
Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor‐Node‐Metastasis Staging System (eighth edition).
- Published in:
- Clinical Endocrinology, 2019, v. 91, n. 2, p. 331, doi. 10.1111/cen.13910
- By:
- Publication type:
- Article
Response to therapy of papillary thyroid cancer of known BRAF status.
- Published in:
- Clinical Endocrinology, 2017, v. 87, n. 6, p. 815, doi. 10.1111/cen.13423
- By:
- Publication type:
- Article
The BRAF<sup>V</sup><sup>600E</sup> mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
- Published in:
- Clinical Endocrinology, 2014, v. 80, n. 6, p. 899, doi. 10.1111/cen.12386
- By:
- Publication type:
- Article
Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179691
- By:
- Publication type:
- Article